Loader

Pathways

PathWhiz ID Pathway Meta Data

PW128327

Pw128327 View Pathway
drug action

Phentermine Norepinephrine Reuptake transporter Satiety Action Pathway

Homo sapiens
Phentermine is an amine anorectic agent used in weight reduction in cases of exogenous obesity as an adjunct or alone. It is chemically related to amphetamine. It is thought that the primary way phentermine works is by inducing a reduction in appetite, potentially through the elevation of leptin levels. However, it's believed that there are likely additional mechanisms to help reduce the weight. This molecule also acts by releasing more noradrenaline from the presynaptic vesicles situated in the lateral hypothalamus. This elevation in this hormone's concentration within the synaptic cleft triggers the activation of beta2-adrenergic receptors. This drug also impacts dopamine levels, along with its consequential influence on serotonin. These combined effects lead to a continuous fight-or-flight response within the body, diminishing hunger signals. Phentermine inhibits the sodium-dependent noradrenaline transporter, the sodium-dependent serotonin transporter, and the sodium-dependent dopamine transporter. This drug is administered as an oral capsule.

PW128346

Pw128346 View Pathway
drug action

Phentermine Serotonin Reuptake transporter Satiety Action Pathway

Homo sapiens
Phentermine is an amine anorectic agent used in weight reduction in cases of exogenous obesity as an adjunct or alone. It is chemically related to amphetamine. It is thought that the primary way phentermine works is by inducing a reduction in appetite, potentially through the elevation of leptin levels. However, it's believed that there are likely additional mechanisms to help reduce the weight. This molecule also acts by releasing more noradrenaline from the presynaptic vesicles situated in the lateral hypothalamus. This elevation in this hormone's concentration within the synaptic cleft triggers the activation of beta2-adrenergic receptors. This drug also impacts dopamine levels, along with its consequential influence on serotonin. These combined effects lead to a continuous fight-or-flight response within the body, diminishing hunger signals. Phentermine inhibits the sodium-dependent noradrenaline transporter, the sodium-dependent serotonin transporter, and the sodium-dependent dopamine transporter. This drug is administered as an oral capsule.

PW144804

Pw144804 View Pathway
drug action

Phentolamine Drug Metabolism Action Pathway

Homo sapiens

PW176116

Pw176116 View Pathway
metabolic

Phentolamine Predicted Metabolism Pathway new

Homo sapiens
Metabolites of Phentolamine are predicted with biotransformer.

PW145809

Pw145809 View Pathway
drug action

Phenyl aminosalicylate Drug Metabolism Action Pathway

Homo sapiens

PW146213

Pw146213 View Pathway
drug action

Phenyl salicylate Drug Metabolism Action Pathway

Homo sapiens

PW250842

Pw250842 View Pathway
metabolic

Phenylacetate degradation

Klebsiella electrica
Phenylacetate degradation involves multiple enzymatic reactions that allow the bacterium to use phenylacetate as a carbon and energy source. Due to its hydrophobic nature, phenylacetate can enter bacterial cells via passive diffusion across the cell membrane. Once inside the cell, the enzyme phenylacetate-CoA ligase activates phenylacetate, converting it to phenylacetyl-CoA. This intermediate passes through several enzymatic processes, including oxidation, hydration, and cleavage, to produce metabolites like acetyl-CoA and succinyl-CoA, which then enter the citrate cycle for energy generation and biosynthesis.

PW088227

Pw088227 View Pathway
metabolic

Phenylacetate Metabolism

Bos taurus
Phenylacetate (or phenylacetic acid) metabolism involves two steps. The first step is the conversion of phenylacetate into phenylacetyl-CoA which is catalyzed by acyl-coenzyme A synthetase ACSM1 or acyl-coenzyme A synthetase ACSM2B. Coenzyme A and ATP are also involved in this first step and AMP and pyrophosphate will be generated during the first step of metabolism. In the second step, phenylacetyl-CoA and L-glutamine interacts with glycine N-acyltransferase to generate coenzyme A as well as phenylacetylglutamine, of which the latter will be excreted in the urine. Phenylacetate metabolism provides a route that facilitates the excretion of nitrogen for patients with urea cycle defects; hence, it is important for clinical purposes.

PW088323

Pw088323 View Pathway
metabolic

Phenylacetate Metabolism

Rattus norvegicus
Phenylacetate (or phenylacetic acid) metabolism involves two steps. The first step is the conversion of phenylacetate into phenylacetyl-CoA which is catalyzed by acyl-coenzyme A synthetase ACSM1 or acyl-coenzyme A synthetase ACSM2B. Coenzyme A and ATP are also involved in this first step and AMP and pyrophosphate will be generated during the first step of metabolism. In the second step, phenylacetyl-CoA and L-glutamine interacts with glycine N-acyltransferase to generate coenzyme A as well as phenylacetylglutamine, of which the latter will be excreted in the urine. Phenylacetate metabolism provides a route that facilitates the excretion of nitrogen for patients with urea cycle defects; hence, it is important for clinical purposes.

PW000033

Pw000033 View Pathway
metabolic

Phenylacetate Metabolism

Homo sapiens
Phenylacetate (or phenylacetic acid) metabolism involves two steps. The first step is the conversion of phenylacetate into phenylacetyl-CoA which is catalyzed by acyl-coenzyme A synthetase ACSM1 or acyl-coenzyme A synthetase ACSM2B. Coenzyme A and ATP are also involved in this first step and AMP and pyrophosphate will be generated during the first step of metabolism. In the second step, phenylacetyl-CoA and L-glutamine interacts with glycine N-acyltransferase to generate coenzyme A as well as phenylacetylglutamine, of which the latter will be excreted in the urine. Phenylacetate metabolism provides a route that facilitates the excretion of nitrogen for patients with urea cycle defects; hence, it is important for clinical purposes.